Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin lock concentration for prevention of PICC-related thrombosis in patients with malignant tumors
ChiCTR1800018391Phase 3Recruiting
- Sponsor
- Guangzhou First People's Hospital
- Start
- Jul 2017
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of heparin and saline in upper extremity deep vein thrombosis (UEDVT) (3 arms), sponsored by Guangzhou First People's Hospital. Primary endpoint: Incidence of upper extremity venous thrombosis. Started Jul 2017; status: recruiting.
02
Drugs
heparinsaline
03
Conditions
upper extremity deep vein thrombosis (UEDVT)
Beyond the preview
Go deeper on ChiCTR1800018391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018391.